Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...
Simultaneous use of cannabis with nicotine and tobacco products is common among cannabis users—particularly those who vape—according to a new study ...
Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.
Palvella Therapeutics reports Phase 2 data showing 73% improvement with QTORIN rapamycin gel in cutaneous venous ...
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
Cardamyst is supplied as a carton of 2 disposable nasal spray devices, each delivering 2 sprays containing a total of 70mg of etripamil.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback